JP2019532275A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532275A5
JP2019532275A5 JP2019511411A JP2019511411A JP2019532275A5 JP 2019532275 A5 JP2019532275 A5 JP 2019532275A5 JP 2019511411 A JP2019511411 A JP 2019511411A JP 2019511411 A JP2019511411 A JP 2019511411A JP 2019532275 A5 JP2019532275 A5 JP 2019532275A5
Authority
JP
Japan
Prior art keywords
group
hapten
target
carbon atoms
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019511411A
Other languages
English (en)
Japanese (ja)
Other versions
JP7033122B2 (ja
JP2019532275A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/049153 external-priority patent/WO2017040349A1/en
Application filed filed Critical
Publication of JP2019532275A publication Critical patent/JP2019532275A/ja
Publication of JP2019532275A5 publication Critical patent/JP2019532275A5/ja
Application granted granted Critical
Publication of JP7033122B2 publication Critical patent/JP7033122B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019511411A 2015-08-28 2017-08-25 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ Active JP7033122B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562211590P 2015-08-28 2015-08-28
US201662301489P 2016-02-29 2016-02-29
USPCT/US2016/049153 2016-08-26
PCT/US2016/049153 WO2017040349A1 (en) 2015-08-28 2016-08-26 Protein proximity assay in formalin fixed paffafin embedded tissue using caged haptens
PCT/US2017/048687 WO2018039605A1 (en) 2015-08-28 2017-08-25 Protein proximity assay in formalin fixed paraffin embedded tissue using caged haptens

Publications (3)

Publication Number Publication Date
JP2019532275A JP2019532275A (ja) 2019-11-07
JP2019532275A5 true JP2019532275A5 (enExample) 2020-09-24
JP7033122B2 JP7033122B2 (ja) 2022-03-09

Family

ID=58188142

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018510803A Active JP6880001B2 (ja) 2015-08-28 2016-08-26 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ
JP2019511411A Active JP7033122B2 (ja) 2015-08-28 2017-08-25 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018510803A Active JP6880001B2 (ja) 2015-08-28 2016-08-26 ケージドハプテンを使用するホルマリン固定パラフィン包埋組織におけるタンパク質近接アッセイ

Country Status (7)

Country Link
US (6) US11053266B2 (enExample)
EP (1) EP3341734B1 (enExample)
JP (2) JP6880001B2 (enExample)
CN (3) CN107923915B (enExample)
AU (3) AU2016316846B2 (enExample)
CA (1) CA2996798A1 (enExample)
WO (2) WO2017040349A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107923915B (zh) * 2015-08-28 2021-05-04 文塔纳医疗系统公司 使用经掩蔽的半抗原在福尔马林固定石蜡包埋的组织中的蛋白质邻近测定
EP3894397A4 (en) * 2018-12-10 2022-09-28 Ariel Scientific Innovations Ltd. THERAPEUTIC CONJUGATES
CN110632040B (zh) * 2019-05-10 2022-03-29 长沙理工大学 一种血清中前列腺特异性抗原的分析方法
JP7644750B2 (ja) * 2019-08-28 2025-03-12 ベンタナ メディカル システムズ， インコーポレイテッド 振動分光法による抗原回収および標的回収進行量の評価
EP4147054A1 (en) * 2020-05-07 2023-03-15 Ventana Medical Systems, Inc. Histochemical systems and methods for evaluating egfr and egfr ligand expression in tumor samples
CN116783485A (zh) * 2021-01-15 2023-09-19 文塔纳医疗系统公司 储存稳定的笼状半抗原
CN114994329A (zh) * 2022-04-28 2022-09-02 杭州广科安德生物科技有限公司 一种检测肿瘤组织中p185蛋白与p95蛋白表达水平的方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2730523A (en) * 1952-08-16 1956-01-10 Eastman Kodak Co 5-nitrothiazoleazo-n-fluoroalkyl-aniline compounds
ATE159760T1 (de) * 1988-07-08 1997-11-15 Jbl Scient Inc Herstellung und verwendung von fluoreszierenden benzothiazolderivaten
US5182203A (en) * 1989-03-29 1993-01-26 E. I. Du Pont De Nemours And Company Bifunctional compounds useful in catalyzed reporter deposition
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5595707A (en) 1990-03-02 1997-01-21 Ventana Medical Systems, Inc. Automated biological reaction apparatus
US5371241A (en) * 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
GB9517060D0 (en) * 1995-08-17 1995-10-25 Ciba Geigy Ag Acylated oligopeptide derivatives
US20030235877A1 (en) * 1996-04-30 2003-12-25 La Region Wallone Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
US6582962B1 (en) 1998-02-27 2003-06-24 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
AU763354B2 (en) 1998-02-27 2003-07-17 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US20030211630A1 (en) 1998-02-27 2003-11-13 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US20060040319A1 (en) * 2000-01-14 2006-02-23 Tom Muir Multiple sensor-containing active modified polypeptides, preparation and uses thereof
CA2456590A1 (en) * 2001-08-07 2003-02-20 Merck & Co., Inc. Biological assay detection method
ES2741524T3 (es) * 2004-03-23 2020-02-11 Ascendis Pharma Gmbh Profármaco polimérico con un enlazador autoinmolador
AU2006239315B2 (en) 2005-04-28 2012-03-01 Ventana Medical Systems, Inc. Enzymes conjugated to antiobodies via a PEG heterobifuctional linker
EP3095467B1 (en) 2005-11-23 2020-05-06 Ventana Medical Systems, Inc. Antibody-enzyme conjugate
DK2078197T3 (en) 2006-11-01 2016-05-23 Ventana Med Syst Inc Haptenes, hapten conjugates, compositions thereof and processes for their preparation and use
US20080220434A1 (en) * 2007-02-07 2008-09-11 Perscitus Biosciences, Llc Detection Of Molecule Proximity
EP3561513A1 (en) 2007-05-23 2019-10-30 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
CA2730565A1 (en) * 2007-07-27 2009-02-05 Ensemble Discovery Corporation Detection assays and use thereof
CA2734783C (en) 2008-08-22 2016-04-19 Ventana Medical Systems, Inc. Method for chromogenic detection of two or more target molecules in a single sample
EP2993478B1 (en) 2009-10-19 2022-08-24 Ventana Medical Systems, Inc. Device and method for slide caching
BR112012012787B1 (pt) * 2009-11-27 2019-12-17 Ecole Polytechnique Fed Lausanne Epfl biossensor para a detecção de difusão de biomoléculas fluorescentes, arranjo, conjunto e método para a detecção e medição de difusão de biomoléculas fluorescentes
ES2593464T3 (es) 2010-12-30 2016-12-09 Ventana Medical Systems, Inc. Deposición potenciada de cromógenos utilizando análogos de pirimidina
US8852599B2 (en) * 2011-05-26 2014-10-07 Bristol-Myers Squibb Company Immunoconjugates, compositions for making them, and methods of making and use
SG2014011084A (en) 2011-09-09 2014-04-28 Ventana Med Syst Inc Imaging systems, cassettes, and methods of using the same
WO2013148498A1 (en) 2012-03-27 2013-10-03 Ventana Medical Systems, Inc. Signaling conjugates and methods of use
WO2014139980A1 (en) * 2013-03-12 2014-09-18 Ventana Medical Systems, Inc. Proximity assay for in situ detection of targets
CN103513039B (zh) * 2013-07-10 2015-12-23 广州美格生物科技有限公司 一种利用定向肽库检测蛋白质与其他分子相互作用的方法
US10241115B2 (en) * 2013-12-10 2019-03-26 Merck Sharp & Dohme Corp. Immunohistochemical proximity assay for PD-1 positive cells and PD-ligand positive cells in tumor tissue
CA2940439C (en) * 2014-02-24 2024-03-19 Ventana Medical Systems, Inc. Quinone methide analog signal amplification
US10550190B2 (en) * 2014-04-04 2020-02-04 Merck Sharp & Dohme Corp. Phosphate based linkers for intracellular delivery of drug conjugates
AU2015352625B2 (en) * 2014-11-25 2019-07-25 Ventana Medical Systems, Inc. Proximity assays using chemical ligation and hapten transfer
EP3037820A1 (en) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Cell detection methods and reagents having a releasable labelling moiety
CN107923915B (zh) * 2015-08-28 2021-05-04 文塔纳医疗系统公司 使用经掩蔽的半抗原在福尔马林固定石蜡包埋的组织中的蛋白质邻近测定

Similar Documents

Publication Publication Date Title
JP2019532275A5 (enExample)
CA1338320C (en) Resorufin derivatives
US8703417B2 (en) Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
US9029092B2 (en) Solution phase homogeneous assays
US4550163A (en) Ligand analog-irreversible enzyme inhibitor conjugates
US8916346B2 (en) Reagents and methods for direct labeling of nucleotides
US20100273189A1 (en) Non separation assays with selective signal inhibitors
US4485177A (en) Creatinine specific antibody
CA2353872A1 (en) Multiple enzyme assays
WO1995017672A1 (en) Chemiluminescent energy transfer assays
JPS60256398A (ja) 試験試料中の白血球、エステラーゼ又はプロテアーゼの存在を測定するための組成物及び試験具
SE448259B (sv) Forfarande for bestemning av ligander i testprover och analytiskt reagens dertill
JPH02504109A (ja) 酵素活性測定方法
JP2004294443A (ja) Ｈｉｖプロテアーゼインヒビターの免疫測定法
JP2018528425A5 (enExample)
CN107652344B (zh) 化合物、缀合物、试剂盒及其在检测睾酮或其类似物中的用途
JP3190730B2 (ja) 新規標識薬物ハプテン類似体を用いるイムノアッセイ
US4543325A (en) Process and reagent for the determination of creatinine
US4595656A (en) Coupling agents and products produced therefrom
RU2102759C1 (ru) Способ обнаружения или количественного определения аналита в образце
GB2050602A (en) Method of and reagents for quantitative determination of cyclic nucleotides
WO1994019691A1 (en) Method and composition for reducing the effects of endogenous alkaline phosphatase
CN114487409B (zh) 一种转肽酶活性的检测方法及检测试剂盒
US5273885A (en) Conjugates of monophenyl thyroid analogs useful in assays
US7537910B2 (en) Lactamase amplification substrate